The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 5×
“This pathway is processing-dependent and it is triggered by certain members of the tumour necrosis factor (TNF) cytokine family that selectively activate the IKKa catalytic subunit, along with another protein kinase called NIK [3,7].”
BackgroundInfluentialActivators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Self-citationTNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Self-citationInterleukin-1 polymorphisms associated with increased risk of gastric cancer
El-Omar, E. M., Carrington, M., Chow, W.-H., McColl, K. E. L., Bream, J. H., Young, H. A., Herrera, J., Lissowska, J., Yuan, C.-C., Rothman, N., et al. (2000) · Nature · doi:10.1038/35006081 · Cited by 2,366
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S.-C., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,359
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Berg, D. J., Davidson, N., Kühn, R., Müller, W., Menon, S., Holland, G., Thompson-Snipes, L., Leach, M. W., & Rennick, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118861 · Cited by 1,136
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Li, Z.-W., Chu, W., Hu, Y., Delhase, M., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1839 · Cited by 926
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Regulation of NF-κB by Cyclin-Dependent Kinases Associated with the p300 Coactivator
Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., & Nabel, G. J. (1997) · Science · doi:10.1126/science.275.5299.523 · Cited by 722
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
Ekbom, A., Adami, H.-O., Helmick, C., & Zack, M. (1990) · The Lancet · doi:10.1016/0140-6736(90)91889-i · Cited by 699
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 519
Redox signaling in macrophages
Jay Forman, H. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(01)00010-3 · Cited by 510
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., & Karin, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00599-2 · Cited by 482
Self-citationNF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003) · Oncogene · doi:10.1038/sj.onc.1206056 · Cited by 430
Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 427
Farrow, D. C., Vaughan, T. L., Hansten, P. D., et al. (1998) · PubMed · Cited by 416
Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells
Keates, S., Hitti, Y., Upton, M., & Kelly, C. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322504 · Cited by 414
A requirement for NF-kappa B activation in Bcr-Abl-mediated transformation
Reuther, J. Y., Reuther, G. W., Cortez, D., Pendergast, A. M., & Baldwin Jr., A. S. (1998) · Genes & Development · doi:10.1101/gad.12.7.968 · Cited by 392
Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma
Johnson, J. P. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006304806799 · Cited by 294
Xiao, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6805 · Cited by 294
Sequence-specific transactivation of the Drosophila twist gene by the dorsal gene product
Thisse, C., Perrin-Schmitt, F., Stoetzel, C., & Thisse, B. (1991) · Cell · doi:10.1016/0092-8674(91)90014-p · Cited by 235
Montaner, S., Perona, R., Saniger, L., & Lacal, J. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12779 · Cited by 228
Arlt, A., Vorndamm, J., Breitenbroich, M., Fölsch, U. R., Kalthoff, H., Schmidt, W. E., & Schäfer, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204168 · Cited by 227
RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100
Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D., & Paya, C. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109619200 · Cited by 224
IKKα, IKKβ, and NEMO/IKKγ Are Each Required for the NF-κB-mediated Inflammatory Response Program
Li, X., Massa, P. E., Hanidu, A., Peet, G. W., Aro, P., Savitt, A., Mische, S., Li, J., & Marcu, K. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205165200 · Cited by 223
Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., Sandborn, W. J., Lipsky, J. J., & McKean, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26448 · Cited by 217
Proteasome inhibition in cancer: Development of PS-341
ADAMS, J. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90034-x · Cited by 209
Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C
Chilov, D., Kukk, E., Taira, S., Jeltsch, M., Kaukonen, J., Palotie, A., Joukov, V., & Alitalo, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25176 · Cited by 204
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells
Zhou, G., & Kuo, M. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15174 · Cited by 193
Methotrexate Suppresses NF-κB Activation Through Inhibition of IκBα Phosphorylation and Degradation
Majumdar, S., & Aggarwal, B. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2911 · Cited by 192
Proteasome inhibition: a novel approach to cancer therapy
Adams, J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02315-8 · Cited by 180
Bond, M., Baker, A. H., & Newby, A. C. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1551 · Cited by 173
Amit, S., & Ben‐Neriah, Y. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00096-2 · Cited by 160
Cusack, J. C., Liu, R., & Baldwin, A. S. (2000) · PubMed · Cited by 160
Duyao, M. P., Kessler, D. J., Spicer, D. B., Bartholomew, C., Cleveland, J. L., Siekevitz, M., & Sonenshein, G. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41998-9 · Cited by 156
Andela, V. B., Schwarz, E. M., Puzas, J. E., O’Keefe, R. J., & Rosier, R. N. (2000) · PubMed · Cited by 149
NF-κB: arresting a major culprit in cancer
Haefner, B. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02309-7 · Cited by 138
Takeshita, H., Yoshizaki, T., Miller, W. E., Sato, H., Furukawa, M., Pagano, J. S., & Raab‐Traub, N. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5548-5555.1999 · Cited by 127
Ardite, E., Panés, J., Miranda, M., Salas, A., Elizalde, J., Sans, M., Arce, Y., Bordas, J. M., Fernández-Checa, J. C., & Pique, J. M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701887 · Cited by 119
Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosis
Jones, D. R., Broad, R. M., Madrid, L. V., Baldwin, A. S., & Mayo, M. W. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01635-0 · Cited by 109
Rel/NF-κB/IκB signal transduction in the generation and treatment of human cancer
Gilmore, T. D., Gapuzan, M.-E. R., Kalaitzidis, D., & Starczynowski, D. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00795-9 · Cited by 106
Chemopreventive Agents Induce Suppression of Nuclear Factor‐κB Leading to Chemosensitization
Bharti, A. C., & Aggarwal, B. B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04671.x · Cited by 98
INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB
Wolff, B., & Naumann, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202617 · Cited by 85
Kim, H., Lim, J. W., & Kim, K. H. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201300191969 · Cited by 73
Tang, R., Wang, J., Lo, S. K., & Hsieh, L. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990812)82:4<473::aid-ijc1>3.0.co;2-k · Cited by 70
Members of the Nuclear Factor κB Family Transactivate the Murine c-myb Gene
Toth, C., Hostutler, R. F., Baldwin, A. S., & Bender, T. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7661 · Cited by 54
Cited by
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
NF-kB in development and progression of human cancer
Dolcet, X., Llobet, D., Pallares, J., & Matias-Guiu, X. (2005) · Virchows Archiv · doi:10.1007/s00428-005-1264-9 · Cited by 1,169
Metadata
- Authors
- Greten, F.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2004-04-08
- Volume
- 206
- Issue
- 2
- Pages
- 193-199
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2125678075
- Cited by
- 410
- References
- 67
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.